Institutional Ownership Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX). We have compiled data on the 198 institutions that hold shares in the stock, with a total of 68.2 Million shares, which have been reported (via 13F filing form) to have a value of $1.62 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Kynam Capital Management, LP
Princeton, NJ |
Aug 14, 2025 Q2 2025 |
6,100,729
shares
|
$145 Million
14.83% of portfolio
|
Q2 2025
Reduced 6.14%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
5,232,326
shares
|
$125 Million
0.02% of portfolio
|
Q2 2025
Reduced 37.37%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,690,761
shares
|
$112 Million
0.0% of portfolio
|
Q2 2024
Added 3.96%
|
|
Vanguard Group Inc
Valley Forge, PA |
Aug 11, 2025 Q2 2025 |
3,957,122
shares
|
$94.2 Million
0.0% of portfolio
|
Q2 2025
Added 1.51%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
3,817,820
shares
|
$90.9 Million
0.01% of portfolio
|
Q2 2025
Added 11.94%
|
|
Commodore Capital LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,450,000
shares
|
$82.1 Million
6.54% of portfolio
|
Q2 2025
Added 7.81%
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Aug 14, 2025 Q2 2025 |
3,307,569
shares
|
$78.7 Million
1.53% of portfolio
|
Q2 2025
Added 7.68%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Aug 14, 2025 Q2 2025 |
2,801,721
shares
|
$66.7 Million
0.13% of portfolio
|
Q2 2025
Added 6.89%
|
|
State Street Corp
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,405,495
shares
|
$57.3 Million
0.0% of portfolio
|
Q2 2025
Reduced 14.28%
|
|
Deep Track Capital, LP
Greenwich, CT |
Aug 14, 2025 Q2 2025 |
2,000,000
shares
|
$47.6 Million
1.44% of portfolio
|
Q1 2025
Added 29.86%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,794,048
shares
|
$42.7 Million
0.07% of portfolio
|
Q2 2023
Added 130.12%
|
|
Vestal Point Capital, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
1,750,000
shares
|
$41.7 Million
1.87% of portfolio
|
Q2 2025
Added 780.96%
|
|
Geode Capital Management, LLC
Boston, MA |
Aug 08, 2025 Q2 2025 |
1,672,980
shares
|
$39.8 Million
0.0% of portfolio
|
Q2 2025
Added 5.23%
|
|
Woodline Partners LP
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,500,455
shares
|
$35.7 Million
0.17% of portfolio
|
Q2 2025
Added 26.26%
|
|
Eventide Asset Management, LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,356,186
shares
|
$32.3 Million
0.52% of portfolio
|
Q2 2025
Reduced 63.88%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Aug 13, 2025 Q2 2025 |
1,300,329
shares
|
$30.9 Million
0.03% of portfolio
|
Q2 2025
Added 35.76%
|
|
Polar Capital Holdings PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
1,228,435
shares
|
$29.2 Million
0.14% of portfolio
|
Q2 2025
Reduced 12.47%
|
|
Novo Holdings
Hellerup, G7 |
Aug 14, 2025 Q2 2025 |
1,200,000
shares
|
$28.6 Million
2.13% of portfolio
|
Q1 2025
Added 20.0%
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
841,246
shares
|
$20 Million
0.0% of portfolio
|
Q2 2025
Reduced 42.7%
|
|
Eversept Partners, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
838,736
shares
|
$20 Million
1.72% of portfolio
|
Q2 2025
Added 20.42%
|
|
Ken Fisher
Fisher Asset Management, LLC | Camas, Wa
|
Aug 13, 2025 Q2 2025 |
822,208
shares
|
$19.6 Million
0.01% of portfolio
|
Q2 2025
Reduced 5.67%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
812,653
shares
|
$19.3 Million
1.12% of portfolio
|
Q1 2025
Reduced 33.51%
|
|
American Century Companies Inc
Kansas City, MO |
Aug 12, 2025 Q2 2025 |
779,985
shares
|
$18.6 Million
0.01% of portfolio
|
Q2 2025
Added 24.73%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
727,504
shares
|
$17.3 Million
0.0% of portfolio
|
Q2 2025
Added 4.53%
|
|
Baker Bros. Advisors LP
New York, NY |
Aug 14, 2025 Q2 2025 |
665,370
shares
|
$15.8 Million
0.14% of portfolio
|
Q2 2025
Added 168.68%
|